| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 22 |
| 1 | OMEPRAZOLE MAGNESIUM | 18 |
| 2 | OMEPRAZOLE | 17 |
| 3 | METHOTREXATE SODIUM | 16 |
| 4 | VALSARTAN | 16 |
| 5 | 0XYGEN | 14 |
| 6 | ASPIRIN | 14 |
| 7 | ASPIRIN 325 MG | 14 |
| 8 | ASPIRIN 81 MG | 14 |
| 9 | HYDROCHLOROTHIAZIDE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEPIVACAINE HYDROCHLORIDE | 9 | 0.0078 |
| 1 | PANTHENOL | 1 | 0.0034 |
| 2 | VERAPAMIL HYDROCHLORIDE | 9 | 0.0021 |
| 3 | PIROXICAM | 9 | 0.0014 |
| 4 | DEXCHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 5 | SILVER SULFADIAZINE | 2 | 0.0009 |
| 6 | FLUVASTATIN SODIUM | 3 | 0.0007 |
| 7 | IMIGLUCERASE | 3 | 0.0006 |
| 8 | ELIGLUSTAT | 1 | 0.0006 |
| 9 | PAMIDRONATE DISODIUM | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 34 |
| 1 | Corticosteroid [EPC] | 31 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 25 |
| 3 | Loop Diuretic [EPC] | 23 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 20 |
| 5 | Proton Pump Inhibitor [EPC] | 20 |
| 6 | Benzodiazepine [EPC] | 19 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 15 |
| 8 | Thiazide Diuretic [EPC] | 15 |
| 9 | Aldosterone Antagonist [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sulfonamide Antibacterial [EPC] | 2 | 0.0005 |
| 1 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 3 | 0.0004 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | General Anesthetic [EPC] | 13 | 0.0003 |
| 4 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 5 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 6 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 8 | Vitamin K [EPC] | 1 | 0.0001 |
| 9 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |